Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methyl salicylate + menthol is a topical combination drug used to relieve minor pain associated with arthritis, backache, muscle strains, sprains, bruises, and cramps. It acts as a topical analgesic by combining two counterirritants: menthol and methyl salicylate. Menthol produces a cooling sensation followed by vasodilation (widening of blood vessels), which can enhance the penetration of other drugs through the skin and provide an analgesic effect. Methyl salicylate is a derivative of salicylic acid that inhibits cyclooxygenase enzymes (prostaglandin G/H synthase 1 and 2), reducing prostaglandin formation locally to decrease inflammation and pain. The combined action interferes with pain signal transmission in nerves by creating sensations of warmth or coolness at the application site[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methyl salicylate + menthol.